Pharmsynthez (MOEX:LIFE)
Russia · Delayed Price · Currency is RUB 4.505
+0.415 (10.15%)
At close: Jul 8, 2022
Pharmsynthez Balance Sheet
Financials in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 2.19 | 1.52 | 4.98 | 9.17 | 15.3 | 10.41 |
Short-Term Investments | 2.56 | 2.54 | - | - | - | - |
Cash & Short-Term Investments | 4.76 | 4.06 | 4.98 | 9.17 | 15.3 | 10.41 |
Cash Growth | -98.15% | -18.50% | -45.74% | -40.03% | 46.89% | -84.44% |
Accounts Receivable | 193.99 | 193.52 | 297.26 | 72.03 | 69.06 | 66.02 |
Other Receivables | - | - | - | 0.8 | 8.03 | 164.1 |
Receivables | 193.99 | 193.52 | 297.26 | 77.55 | 79.21 | 288.79 |
Inventory | 72.94 | 62.62 | 63.56 | 41.95 | 36.19 | 69.56 |
Prepaid Expenses | - | - | - | 69.38 | 75.54 | 96.32 |
Other Current Assets | 2.6 | 2.08 | 3.99 | 0.04 | 0.04 | 0.04 |
Total Current Assets | 274.29 | 262.27 | 369.79 | 198.1 | 206.27 | 465.13 |
Property, Plant & Equipment | 422.63 | 430.94 | 468.54 | 344.58 | 326.7 | 352.12 |
Long-Term Investments | 783.32 | 781.5 | 793.14 | 33.5 | 125.14 | 487.73 |
Other Intangible Assets | 211.74 | 211.86 | 216.21 | 331.9 | 337.23 | 349.83 |
Long-Term Deferred Tax Assets | 1,044 | 1,041 | 1,086 | 366.61 | 365.25 | 329.17 |
Other Long-Term Assets | - | - | - | 63.23 | 63.23 | 68.2 |
Total Assets | 2,736 | 2,727 | 2,934 | 1,338 | 1,425 | 2,052 |
Accounts Payable | 547.69 | 531.87 | 452.39 | 178.66 | 141.29 | 177.76 |
Accrued Expenses | - | - | - | 105.61 | 104.18 | 83.88 |
Short-Term Debt | 386.19 | 361.85 | 335 | 591.72 | 579.81 | 573.52 |
Current Portion of Long-Term Debt | - | - | - | 103.22 | 41.55 | 35.85 |
Current Portion of Leases | - | - | - | 8.69 | - | 0.95 |
Current Income Taxes Payable | - | - | - | 29.23 | 15.55 | 12.31 |
Other Current Liabilities | 24.58 | 19.96 | 59.38 | 157.93 | 110.95 | 140.58 |
Total Current Liabilities | 958.45 | 913.67 | 846.77 | 1,175 | 993.33 | 1,025 |
Long-Term Debt | - | - | - | 16.55 | 86.85 | 13.2 |
Long-Term Leases | - | - | - | 25.22 | - | - |
Other Long-Term Liabilities | 0.61 | 0.93 | 20.15 | - | - | - |
Total Liabilities | 959.06 | 914.6 | 866.92 | 1,217 | 1,080 | 1,038 |
Common Stock | 2,202 | 2,202 | 2,202 | 1,505 | 1,505 | 1,505 |
Additional Paid-In Capital | 4,853 | 4,853 | 4,853 | 3,531 | 3,531 | 3,531 |
Retained Earnings | -5,278 | -5,242 | -4,988 | -4,445 | -4,238 | -3,540 |
Comprehensive Income & Other | 0 | 0 | 0 | -469.45 | -452.76 | -481.47 |
Total Common Equity | 1,776 | 1,813 | 2,067 | 121.1 | 345.28 | 1,014 |
Shareholders' Equity | 1,776 | 1,813 | 2,067 | 121.1 | 345.28 | 1,014 |
Total Liabilities & Equity | 2,736 | 2,727 | 2,934 | 1,338 | 1,425 | 2,052 |
Total Debt | 386.19 | 361.85 | 335 | 745.4 | 708.21 | 623.52 |
Net Cash (Debt) | -381.43 | -357.79 | -330.02 | -736.23 | -692.91 | -613.1 |
Net Cash Per Share | - | -0.85 | -0.78 | -2.45 | -2.30 | -2.04 |
Filing Date Shares Outstanding | - | 394.06 | 391.31 | 301.01 | 301.01 | 301.01 |
Total Common Shares Outstanding | - | 394.06 | 391.31 | 301.01 | 301.01 | 301.01 |
Working Capital | -684.16 | -651.4 | -476.98 | -976.95 | -787.05 | -559.73 |
Book Value Per Share | - | 4.60 | 5.28 | 0.40 | 1.15 | 3.37 |
Tangible Book Value | 1,565 | 1,601 | 1,850 | -210.8 | 8.05 | 664.29 |
Tangible Book Value Per Share | - | 4.06 | 4.73 | -0.70 | 0.03 | 2.21 |
Land | - | - | - | 161.11 | 159.14 | 155.22 |
Machinery | - | - | - | 515.92 | 523.17 | 541 |
Construction In Progress | - | - | - | 143.66 | 143.66 | 143.66 |